Ireland vs Jordan: The number of people with susceptibility test result for rifampicin
Ireland
80
in 2021
Jordan
78.48
in 2021
Ireland rank
94th
Jordan rank
97th
The number of people with susceptibility test result for rifampicin over time
- Ireland
- Jordan
How they compare
Ireland currently reports 80 against 78.48 in Jordan, a difference of 1.52.
The two have swapped places 2 times across 5 shared years of data; in 2017 it was Ireland ahead.
Ireland ranks 94th and Jordan ranks 97th of 146 countries.
Across the 2 decades both report, Ireland averaged higher in 1 and Jordan in 1.
Head to head by decade
| Decade | Ireland | Jordan | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 90.79 | 73.8 | 16.99 | Ireland |
| 2020s | 85.83 | 89.24 | 3.41 | Jordan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Ireland or Jordan?
- Ireland, at 80 against 78.48 in Jordan as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Ireland and Jordan?
- 1.52, with Ireland ahead.
- How many years of comparable data are there for Ireland and Jordan?
- 5 years are reported by both, from 2017 to 2021.
- How do Ireland and Jordan rank globally for the number of people with susceptibility test result for rifampicin?
- Ireland ranks 94th and Jordan ranks 97th of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.